PBAC defends deferral decision

The Department of Health is exploring options to deal with the "highest ever" number of submissions to a PBAC meeting, including using the intracycle meeting to reduce the number of submissions held over to the July meeting, Pharma in Focus has learned.

To see the whole article please log in.

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here